Speaker illustration

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)

Dr Ballantyne is the Chief of Cardiology and Cardiovascular Reserach at Baylor College of Medicine, a Professor in the Departments of Medicine, Genetics and Physiology, and hold the J.S. Abercrombie Chair for Atherosclerosis Research. His major career focus has been in the area of preventive cardiology with research interests in lipoproteins, atherosclerosis, inflammation, biomarkers and genetics in both clinican and basic research.

PCSK9 inhibitors from bench to real world: a journey to improve CV outcomes in very high-risk patients

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Prevention

Session type: Industry Live

Thumbnail

Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

Event: ESC CONGRESS 2019

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Thumbnail

State-of-the-art lipid treatment in coronary patients in 2017

Event: ESC CONGRESS 2017

Topic: Lipids (Epidemiology and Prevention)

Session type: Satellite Symposium

Thumbnail

Targeting the high-risk patient: evolving concepts on optimally modifying risk by lipid-modulating therapies

Event: ESC CONGRESS 2015

Topic: Lipids

Session type: EBAC Accredited Educational Programme

Thumbnail

This platform is supported by

logo Novo Nordisk